A comprehensive guide to purchasing and using giritinib

Gilteritinib (Gilteritinib), as an innovative targeted drug for FLT3 mutation-positive acute myeloid leukemia (AML), brings new treatment hope to patients. However, many details of its purchase and use still need to be understood deeply by patients and their families. Below is a comprehensive guide to purchasing and using giritinib.

1. Purchase channels

1. Hospital pharmacies: Domestic regular hospital pharmacies are the first choice for purchasing giritinib. The quality of medicines is guaranteed, but the prices may be higher. Patients need to purchase it with a doctor's prescription.

2. Regular pharmacies: Large chain pharmacies or regular pharmacies with pharmaceutical business qualifications are also one of the ways to purchase. The price may be cheaper than hospital pharmacies, but you need to ensure that the source of the medicine is regular.

3. Overseas medical institutions: For patients with limited financial conditions, you can consider purchasing generic drugs of giritinib through regular overseas channels.

2. How to use

1. Dosage and frequency: The recommended starting dose of giritinib is 120 mg per day, administered orally, and is not affected by diet. Patients should take their medications at approximately the same time each day to maintain stable blood levels.

2. How to take: The tablets should be swallowed whole and should not be broken, crushed or chewed. You can take it with a glass of water to ensure that the medicine enters the body smoothly.

3. Treatment of missed doses: If a dose is missed, the patient should take it as soon as possible on the same day, but the interval between two doses should not be less than 12 hours. If the missed dose exceeds the time of the next dose, there is no need to take it again and you can just continue taking the medicine as originally planned.

3. Precautions

1. Side effect monitoring: During the use of giritinib, patients need to pay close attention to physical reactions. If common side effects such as nausea, vomiting, diarrhea, fatigue, etc. occur, they should inform the doctor in time and follow the doctor's instructions. For serious adverse reactions, the drug should be stopped immediately and seek medical attention.

2. Regular follow-up: Patients should go to the hospital regularly for follow-up examinations, including monitoring of liver function, blood routine and other items, to evaluate the effects of treatment and the impact of drugs on the body.

In short, gilitinib is an effective treatment for specificAML patients, and its purchase and use must be taken seriously by patients and their families. By choosing the appropriate purchasing channel, following the correct usage, and paying close attention to the precautions, you can ensure that patients receive giritinib safely and effectively.